{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T21:06:44Z","timestamp":1771362404122,"version":"3.50.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100028802","name":"Society of Transnational Academic Researchers Scholars Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100028802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jacadv.2025.102287","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:00:18Z","timestamp":1761652818000},"page":"102287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Traditional and HIV-Specific Risk Factors Associated With Atrial Fibrillation Among Underrepresented Minority Groups With HIV"],"prefix":"10.1016","volume":"4","author":[{"given":"Elizabeth A.","family":"Kobe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Clare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Chiswell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9468-0179","authenticated-orcid":false,"given":"Chris T.","family":"Longenecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Marsolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric G.","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nwora Lance","family":"Okeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April","family":"Pettit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caryn G.","family":"Morse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamea","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Vicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gretchen","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald S.","family":"Bloomfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishant P.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2025.102287_bib1","article-title":"Global, regional, and national HIV\/AIDS disease burden levels and trends in 1990-2019: a systematic analysis for the global burden of disease 2019 study","volume":"11","author":"Tian","year":"2023","journal-title":"Front Public Health"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102287_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2991\/jegh.k.210621.001","article-title":"Global epidemiology of HIV\/AIDS: a resurgence in North America and Europe","volume":"11","author":"Govender","year":"2021","journal-title":"J Epidemiol Glob Health"},{"issue":"5","key":"10.1016\/j.jacadv.2025.102287_bib3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/QAI.0000000000001450","article-title":"Increased risk of myocardial infarction in HIV-infected individuals in North America compared with the general population","volume":"75","author":"Drozd","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1016\/j.jacadv.2025.102287_bib4","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.jacadv.2025.102287_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/QAI.0b013e31825c7f24","article-title":"Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system","volume":"60","author":"Chow","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"19","key":"10.1016\/j.jacadv.2025.102287_bib6","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1212\/WNL.0000000000001560","article-title":"HIV status and the risk of ischemic stroke among men","volume":"84","author":"Sico","year":"2015","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jacadv.2025.102287_bib7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archinternmed.2011.151","article-title":"Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease","volume":"171","author":"Butt","year":"2011","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.jacadv.2025.102287_bib8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jamacardio.2017.0264","article-title":"Association between HIV infection and the risk of heart failure with reduced ejection fraction and preserved ejection fraction in the antiretroviral therapy era: results from the veterans aging cohort study","volume":"2","author":"Freiberg","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"22","key":"10.1016\/j.jacadv.2025.102287_bib9","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.jacc.2013.03.022","article-title":"Atrial fibrillation and atrial flutter in human immunodeficiency virus-infected persons: incidence, risk factors, and association with markers of HIV disease severity","volume":"61","author":"Hsu","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102287_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194754","article-title":"Atrial arrhythmia prevalence and characteristics for human immunodeficiency virus-infected persons and matched uninfected controls","volume":"13","author":"Sanders","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102287_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10840-022-01233-w","article-title":"Incidence and risk factors of atrial fibrillation and atrial arrhythmias in people living with HIV: a systematic review and meta-analysis","volume":"65","author":"Park","year":"2022","journal-title":"J Interv Card Electrophysiol"},{"issue":"11","key":"10.1016\/j.jacadv.2025.102287_bib12","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jacc.2019.07.027","article-title":"Human immunodeficiency virus infection and incident atrial fibrillation","volume":"74","author":"Sardana","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.jacadv.2025.102287_bib13","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.jacc.2012.02.024","article-title":"Sudden cardiac death in patients with human immunodeficiency virus infection","volume":"59","author":"Tseng","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2025.102287_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu Rev Med"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102287_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2011.03.011","article-title":"T cell activation predicts carotid artery stiffness among HIV-infected women","volume":"217","author":"Kaplan","year":"2011","journal-title":"Atherosclerosis"},{"issue":"9989","key":"10.1016\/j.jacadv.2025.102287_bib16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the framingham heart study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jacadv.2025.102287_bib17","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke Statistics-2023 update: a report from the American heart association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacadv.2025.102287_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.hroo.2022.07.010","article-title":"Healthcare utilization and costs associated with a diagnosis of incident atrial fibrillation","volume":"3","author":"Deshmukh","year":"2022","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.jacadv.2025.102287_bib19","article-title":"Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies","volume":"532","author":"Emdin","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jacadv.2025.102287_bib20","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis","volume":"354","author":"Odutayo","year":"2016","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.jacadv.2025.102287_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2016.11.052","article-title":"Reply: race and stroke risk in atrial fibrillation: the limitations of a social construct","volume":"69","author":"Kabra","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jacadv.2025.102287_bib22","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1161\/STROKEAHA.123.043160","article-title":"Racial and ethnic differences in the risk of ischemic stroke after nontraumatic intracerebral hemorrhage","volume":"54","author":"Simonetto","year":"2023","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102287_bib23","first-page":"3","article-title":"Evaluating foundational data quality in the national patient-centered clinical research network (PCORnet(R))","volume":"6","author":"Qualls","year":"2018","journal-title":"EGEMS (Wash DC)"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102287_bib24","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archinte.167.3.246","article-title":"Newly detected atrial fibrillation and compliance with antithrombotic guidelines","volume":"167","author":"Glazer","year":"2007","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.jacadv.2025.102287_bib25","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish atrial fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacadv.2025.102287_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jacadv.2025.102287_bib27","first-page":"188","article-title":"Charlson comorbidity index: ICD-9 update and ICD-10 translation","volume":"12","author":"Glasheen","year":"2019","journal-title":"Am Health Drug Benefits"},{"issue":"8","key":"10.1016\/j.jacadv.2025.102287_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.14874","article-title":"Trends in atrial fibrillation incidence rates within an integrated health care delivery system, 2006 to 2018","volume":"3","author":"Williams","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102287_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCOUTCOMES.111.962688","article-title":"Incidence and prevalence of atrial fibrillation and associated mortality among medicare beneficiaries, 1993-2007","volume":"5","author":"Piccini","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"10.1016\/j.jacadv.2025.102287_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55838","article-title":"Prevalence and incidence of atrial fibrillation among older primary care patients","volume":"6","author":"Khurshid","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacadv.2025.102287_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.amjcard.2020.08.029","article-title":"Comparison of frequency of atrial fibrillation in blacks versus whites and the utilization of race in a novel risk score","volume":"135","author":"Kowlgi","year":"2020","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.jacadv.2025.102287_bib32","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jamacardio.2016.1185","article-title":"Genetic investigation into the differential risk of atrial fibrillation among black and white individuals","volume":"1","author":"Roberts","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"22","key":"10.1016\/j.jacadv.2025.102287_bib33","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1161\/CIR.0000000000000042","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American college of cardiology\/American heart association task force on performance measures and task force on practice guidelines","volume":"129","author":"Anderson","year":"2014","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jacadv.2025.102287_bib34","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jama.2020.0734","article-title":"US health care spending by payer and health condition, 1996-2016","volume":"323","author":"Dieleman","year":"2020","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.jacadv.2025.102287_bib35","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/CIR.0000000000000312","article-title":"Further evolution of the ACC\/AHA clinical practice guideline recommendation classification system: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"133","author":"Halperin","year":"2016","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.jacadv.2025.102287_bib36","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCULATIONAHA.110.009035","article-title":"Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the atherosclerosis risk in communities (ARIC) study","volume":"123","author":"Huxley","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102287_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12920-021-00915-0","article-title":"Genetically determined tobacco and alcohol use and risk of atrial fibrillation","volume":"14","author":"Lu","year":"2021","journal-title":"BMC Med Genomics"},{"issue":"19","key":"10.1016\/j.jacadv.2025.102287_bib38","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jacadv.2025.102287_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamacardio.2021.5010","article-title":"Individualized studies of triggers of paroxysmal atrial fibrillation: the I-STOP-AFib randomized clinical trial","volume":"7","author":"Marcus","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"10","key":"10.1016\/j.jacadv.2025.102287_bib40","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/jamacardio.2022.2825","article-title":"Sex differences in atrial fibrillation risk: the VITAL rhythm study","volume":"7","author":"Siddiqi","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"18","key":"10.1016\/j.jacadv.2025.102287_bib41","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1161\/CIR.0000000000000128","volume":"130","author":"Arnett","year":"2014","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.jacadv.2025.102287_bib42","doi-asserted-by":"crossref","first-page":"e879","DOI":"10.1161\/CIR.0000000000000651","article-title":"Recent innovations, modifications, and evolution of ACC\/AHA clinical practice guidelines: an update for our constituencies: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Levine","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102287_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10654-020-00618-3","article-title":"Environmental factors, serum biomarkers and risk of atrial fibrillation: an exposure-wide umbrella review of meta-analyses","volume":"35","author":"Belbasis","year":"2020","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"10.1016\/j.jacadv.2025.102287_bib44","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/eurheartj\/eht483","article-title":"Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke","volume":"35","author":"Piccini","year":"2014","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacadv.2025.102287_bib45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.chest.2017.10.001","article-title":"Lifetime risks, projected numbers, and adverse outcomes in Asian patients with atrial fibrillation: a report from the Taiwan nationwide AF cohort study","volume":"153","author":"Chao","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jacadv.2025.102287_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100888","article-title":"Optimizing cardiometabolic risk in people living with human immunodeficiency virus: a deep dive into an important risk enhancer","volume":"20","author":"Kobe","year":"2024","journal-title":"Am J Prev Cardiol"},{"issue":"17","key":"10.1016\/j.jacadv.2025.102287_bib47","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Group","year":"2007","journal-title":"N Engl J Med"},{"issue":"9622","key":"10.1016\/j.jacadv.2025.102287_bib48","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(08)60423-7","article-title":"Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration","volume":"371","author":"Group","year":"2008","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.jacadv.2025.102287_bib49","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1177\/09564624231196599","article-title":"The risk of new heart failure associated with protease inhibitor: systematic scoping review","volume":"34","author":"Gozun","year":"2023","journal-title":"Int J STD AIDS"},{"issue":"5","key":"10.1016\/j.jacadv.2025.102287_bib50","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004987","article-title":"Changes in cardiovascular disease risk factors with immediate versus deferred antiretroviral therapy initiation among HIV-positive participants in the START (strategic timing of antiretroviral treatment) trial","volume":"6","author":"Baker","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"18","key":"10.1016\/j.jacadv.2025.102287_bib51","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1097\/QAD.0000000000001675","article-title":"Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk","volume":"31","author":"Gatell","year":"2017","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102287_bib52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/QAD.0b013e32834e8776","article-title":"Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment","volume":"26","author":"Capeau","year":"2012","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102287_bib53","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00126334-200303010-00009","article-title":"Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women","volume":"32","author":"Justman","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102287_bib54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1086\/518619","article-title":"Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV cohort study","volume":"45","author":"Ledergerber","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.jacadv.2025.102287_bib55","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/dme.12455","article-title":"Incidence of diabetes mellitus in a population-based cohort of HIV-infected and non-HIV-infected persons: the impact of clinical and therapeutic factors over time","volume":"31","author":"Tripathi","year":"2014","journal-title":"Diabet Med"},{"issue":"8","key":"10.1016\/j.jacadv.2025.102287_bib56","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0149-2918(00)80064-8","article-title":"Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity","volume":"22","author":"Moyle","year":"2000","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102287_bib57","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.23716","article-title":"Clinical syndromes and consequences of antiretroviral-related hepatotoxicity","volume":"52","author":"Nunez","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jacadv.2025.102287_bib58","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ajg.2014.32","article-title":"Risk factors for fatty liver in the multicenter AIDS cohort study","volume":"109","author":"Price","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.jacadv.2025.102287_bib59","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/jac\/dky145","article-title":"Obesity following ART initiation is common and influenced by both traditional and HIV-\/ART-specific risk factors","volume":"73","author":"Bakal","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.jacadv.2025.102287_bib60","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/cid\/ciz407","article-title":"Greater weight gain in treatment-naive persons starting dolutegravir-based antiretroviral therapy","volume":"70","author":"Bourgi","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102287_bib61","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/COH.0000000000000833","article-title":"Recent data on the role of antiretroviral therapy in weight gain and obesity in persons living with HIV","volume":"19","author":"Capeau","year":"2024","journal-title":"Curr Opin HIV AIDS"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102287_bib62","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jac\/dkad007","article-title":"Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort","volume":"78","author":"Grabar","year":"2023","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.jacadv.2025.102287_bib63","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/QAD.0000000000001495","article-title":"Dolutegravir and weight gain: an unexpected bothering side effect?","volume":"31","author":"Menard","year":"2017","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.jacadv.2025.102287_bib64","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/QAI.0000000000001525","article-title":"Brief report: weight gain in persons with HIV switched from efavirenz-based to integrase strand transfer inhibitor-based regimens","volume":"76","author":"Norwood","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"10.1016\/j.jacadv.2025.102287_bib65","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/QAD.0000000000002245","article-title":"Dolutegravir monotherapy and body weight gain in antiretroviral naive patients","volume":"33","author":"Rizzardo","year":"2019","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.jacadv.2025.102287_bib66","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/cid\/ciz999","article-title":"Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials","volume":"71","author":"Sax","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jacadv.2025.102287_bib67","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1016\/S2352-3018(23)00328-4","volume":"11","author":"Byonanebye","year":"2024","journal-title":"Lancet HIV"},{"issue":"10","key":"10.1016\/j.jacadv.2025.102287_bib68","article-title":"The impact of contemporary antiretroviral drugs on atherosclerosis and its complications in people living with HIV: a systematic review","volume":"15","author":"Vemulapalli","year":"2023","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102287_bib69","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study","volume":"201","author":"Worm","year":"2010","journal-title":"J Infect Dis"},{"issue":"13","key":"10.1016\/j.jacadv.2025.102287_bib70","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/00002030-200409030-00010","article-title":"Cardio- and cerebrovascular events in HIV-infected persons","volume":"18","author":"d'Arminio","year":"2004","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.jacadv.2025.102287_bib71","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/S2352-3018(18)30043-2","article-title":"Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study","volume":"5","author":"Ryom","year":"2018","journal-title":"Lancet HIV"},{"issue":"7","key":"10.1016\/j.jacadv.2025.102287_bib72","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S2352-3018(22)00094-7","article-title":"Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium","volume":"9","author":"Neesgaard","year":"2022","journal-title":"Lancet HIV"},{"issue":"10","key":"10.1016\/j.jacadv.2025.102287_bib73","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/eurheartj\/ehz873","article-title":"One-year outcomes in atrial fibrillation presenting during infections: a nationwide registry-based study","volume":"41","author":"Gundlund","year":"2020","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacadv.2025.102287_bib74","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002399","article-title":"The association between COVID-19 infection and incident atrial fibrillation: results from a retrospective cohort study using a large US commercial insurance database","volume":"10","author":"Berman","year":"2023","journal-title":"Open Heart"},{"issue":"6","key":"10.1016\/j.jacadv.2025.102287_bib75","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/s13054-014-0688-5","article-title":"Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review","volume":"18","author":"Kuipers","year":"2014","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.jacadv.2025.102287_bib76","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/655144","article-title":"Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study","volume":"51","author":"Lichtenstein","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jacadv.2025.102287_bib77","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/QAI.0000000000000009","article-title":"Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care","volume":"65","author":"Silverberg","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"10.1016\/j.jacadv.2025.102287_bib78","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/QAI.0b013e3181f4b752","article-title":"Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system","volume":"55","author":"Triant","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.jacadv.2025.102287_bib79","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/QAD.0b013e328333ea9e","article-title":"Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men","volume":"24","author":"Lo","year":"2010","journal-title":"AIDS"},{"issue":"17","key":"10.1016\/j.jacadv.2025.102287_bib80","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1097\/QAD.0000000000000452","article-title":"Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infection","volume":"28","author":"Chow","year":"2014","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102287_bib81","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/01.STR.0000105393.57853.11","article-title":"Acquired immunodeficiency syndrome and the risk of stroke","volume":"35","author":"Cole","year":"2004","journal-title":"Stroke"},{"issue":"13","key":"10.1016\/j.jacadv.2025.102287_bib82","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1097\/QAD.0000000000000352","article-title":"HIV infection and incidence of ischemic stroke","volume":"28","author":"Marcus","year":"2014","journal-title":"AIDS"},{"issue":"16","key":"10.1016\/j.jacadv.2025.102287_bib83","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1177\/2047487317732432","article-title":"Clinical characteristics of HIV-infected patients with adjudicated heart failure","volume":"24","author":"Steverson","year":"2017","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"10.1016\/j.jacadv.2025.102287_bib84","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003371","article-title":"Inflammatory markers associated with subclinical coronary artery disease: the multicenter AIDS cohort study","volume":"5","author":"Bahrami","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.jacadv.2025.102287_bib85","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/infdis\/jir520","article-title":"Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients","volume":"204","author":"Burdo","year":"2011","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.jacadv.2025.102287_bib86","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/infdis\/jiu594","article-title":"Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection","volume":"211","author":"McKibben","year":"2015","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.jacadv.2025.102287_bib87","doi-asserted-by":"crossref","first-page":"e604","DOI":"10.1093\/cid\/ciaa284","article-title":"Utilization of direct oral anticoagulants in people living with human immunodeficiency virus: observational data from the District of Columbia cohort","volume":"71","author":"George","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jacadv.2025.102287_bib88","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/08971900211034258","article-title":"Analysis of direct oral anticoagulant therapy with concomitant use of interacting antiretroviral agents","volume":"36","author":"Brazeale","year":"2023","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.jacadv.2025.102287_bib89","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2021.01.020","article-title":"Management of anticoagulation in patients with human immunodeficiency virus\/acquired immunodeficiency virus","volume":"200","author":"Sabourin","year":"2021","journal-title":"Thromb Res"},{"issue":"22","key":"10.1016\/j.jacadv.2025.102287_bib90","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026723","article-title":"Trends in oral anticoagulant use among 436 864 patients with atrial fibrillation in community practice, 2011 to 2020","volume":"11","author":"Navar","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.jacadv.2025.102287_bib91","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/europace\/euab303","article-title":"Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis","volume":"24","author":"Grymonprez","year":"2022","journal-title":"Europace"},{"issue":"12","key":"10.1016\/j.jacadv.2025.102287_bib92","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1253\/circj.CJ-19-0527","article-title":"Prevalence and associated stroke risk of human immunodeficiency virus-infected patients with atrial fibrillation - a nationwide cohort study","volume":"83","author":"Jung","year":"2019","journal-title":"Circ J"},{"issue":"12","key":"10.1016\/j.jacadv.2025.102287_bib93","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1001\/jamacardio.2022.3704","article-title":"Association of race and ethnicity with oral anticoagulation and associated outcomes in patients with atrial fibrillation: findings from the get with the guidelines-atrial fibrillation registry","volume":"7","author":"Essien","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.jacadv.2025.102287_bib94","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/STROKEAHA.118.023959","article-title":"Disparities and temporal trends in the use of anticoagulation in patients with ischemic stroke and atrial fibrillation","volume":"50","author":"Sur","year":"2019","journal-title":"Stroke"},{"issue":"25","key":"10.1016\/j.jacadv.2025.102287_bib95","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.jacc.2021.04.110","article-title":"Racial and ethnic considerations in patients with atrial fibrillation: JACC focus seminar 5\/9","volume":"78","author":"Norby","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102287_bib96","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/s41598-022-05816-5","article-title":"Analysis of antiretroviral therapy switch rate and switching pattern for people living with HIV from a national database in Japan","volume":"12","author":"Naito","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jacadv.2025.102287_bib97","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s15010-020-01469-6","article-title":"Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV cohort 2005-2017","volume":"48","author":"Stecher","year":"2020","journal-title":"Infection"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25007161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25007161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T20:07:47Z","timestamp":1771358867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X25007161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":97,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2772963X25007161"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.102287","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traditional and HIV-Specific Risk Factors Associated With Atrial Fibrillation Among Underrepresented Minority Groups With HIV","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.102287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102287"}}